Kris Jacobs Vacancies Kris Jacobs Kris Jacobs Loading jobs... Stay updated Sign up to stay updated and find out how you can get involved. Email Address Data protection consent Read, watch, share Filter by - Any -BlogEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Photo credit: Pablo Garrigos/MSF Press release Press release | 04 October 2023 HIV/AIDS Intellectual property and trade In step to expand people's access to HIV treatment, Colombia plans to overcome patent barriers and issue a compulsory license 5 min Photo credit: Negin Allamehzadeh Press release Press release | 30 September 2023 Tuberculosis MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key TB drug bedaquiline in low- and middle-income countries 3 min Fact sheet | 22 September 2023 Tuberculosis Tuberculosis: Challenges and Breakthroughs Photo credit: Prem Hessenkamp Press release Press release | 22 September 2023 Tuberculosis Commitments made in today's UN TB Declaration to scale up TB testing and treatment, and improve TB care for children, require immediate, concrete action 5 min Newsletter Newsletter | 21 September 2023 Tuberculosis Time for $5 Flash Update: Cepheid and Danaher announce TB test price drop! Letter | 21 September 2023 Intellectual property and trade Ukraine Ukraine: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis Letter | 21 September 2023 Intellectual property and trade Republic of Moldova Moldova: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis Letter | 21 September 2023 Tuberculosis Ukraine Ukraine: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis Load More
Photo credit: Pablo Garrigos/MSF Press release Press release | 04 October 2023 HIV/AIDS Intellectual property and trade In step to expand people's access to HIV treatment, Colombia plans to overcome patent barriers and issue a compulsory license 5 min
Photo credit: Negin Allamehzadeh Press release Press release | 30 September 2023 Tuberculosis MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key TB drug bedaquiline in low- and middle-income countries 3 min
Photo credit: Prem Hessenkamp Press release Press release | 22 September 2023 Tuberculosis Commitments made in today's UN TB Declaration to scale up TB testing and treatment, and improve TB care for children, require immediate, concrete action 5 min
Newsletter Newsletter | 21 September 2023 Tuberculosis Time for $5 Flash Update: Cepheid and Danaher announce TB test price drop!
Letter | 21 September 2023 Intellectual property and trade Ukraine Ukraine: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis
Letter | 21 September 2023 Intellectual property and trade Republic of Moldova Moldova: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis
Letter | 21 September 2023 Tuberculosis Ukraine Ukraine: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis
